Prostate Cancer Treatment Considerations in Patients of Low Socioeconomic Status
Men of low socioeconomic status (SES) are more likely to present with metastases when they are diagnosed with prostate cancer... Read More
Prostate Cancer Mortality, Treatment in the US Differ By Region
Prostate cancer (PCa) epidemiology and management in the United States have been found to differ across regions. It is well... Read More
Prostate Cancer Salvage Combo Benefits Confirmed
Final results of a phase 3 trial confirm the progression-free survival (PFS) benefit of adding short-term androgen suppression to radiotherapy... Read More
Active Surveillance May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer
New findings support the safety of including selected men with Gleason 3+4 prostate cancer in active surveillance (AS) programs, Australian researchers reported... Read More
Predictors of Adverse Pathology After Prostate Cancer Surgery ID’d
PSA level greater than 4.5 ng/mL and the presence of more than 2 positive biopsy cores are the optimal values... Read More
Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer
Early detection of prostate cancer in the United States has resulted in a decrease in the number of men presenting... Read More